SARAH B. KAVANAGH - Corporate Board Profile

Bausch Health Companies Inc.

Filing Date	Source Excerpt
2017-03-23	Ms. Kavanagh has been serving on the Board since July 2016. The Board has determined that Ms. Kavanagh’s extensive experience of complex financial and capital market issues at various banking institutions, and her in-depth knowledge of financial and operational matters qualify her to serve as a member of the Board and the committee on which she sits.
2018-03-21	Sarah B. Kavanagh Toronto, Canada Age 61 Independent 0 Common Shares 39,864 RSUs (comprised of 14,458 vested RSUs — $222,653 and 25,406 unvested RSUs — $391,252) No Options Total Equity Value at Risk: $222,653, representing 45% of the Company’s current aggregate amount of $500,000 required under the share ownership guidelines for non-management Directors and 223% of the Director’s annual retainer. 2017 Meeting Attendance: Board — 8/8; Audit and Risk Committee — 10/10; Nominating and Corporate Governance Committee — 6/6. Director Compensation Table: Sarah B. Kavanagh Fees Earned or Paid in Cash ($): 120,885 Stock Awards ($): 249,995 All Other Compensation ($): — Total ($): 370,880
2019-03-18	Sarah B. Kavanagh Age 62 Independent 2018 Meeting Attendance: Board 5/5 Audit and Risk Committee 8/8 Nominating and Corporate Governance Committee 4/4 Finance and Transactions Committee 1/1 Director Compensation Table: Sarah B. Kavanagh Fees Earned or Paid in Cash: 130,018 Stock Awards: 250,000 All Other Compensation: 0 Total: 380,018
2020-03-16	Sarah B. Kavanagh Age 63 Independent 2019 Meeting Attendance: Board 6/6, Audit and Risk Committee 8/8, Nominating and Corporate Governance Committee 4/4, Finance and Transactions Committee 7/7. Director Compensation Table: Fees Earned or Paid in Cash $135,000, Stock Awards $250,000, Total $385,000.
2021-03-18	Sarah B. Kavanagh Ontario, Canada Age 64 Independent Stock Ownership: 0 Common Shares $0 75,415 RSUs (comprised of 64,378 vested RSUs $2,044,002, and 11,037 unvested RSUs $350,425) Total Equity Value at Risk: $2,044,002, representing 409% of the Company’s current aggregate amount of $500,000 required under the share ownership guidelines for non-employee Directors and 2,044% of the annual Board retainer. 2020 Meeting Attendance: Board 8/9 Audit and Risk Committee 9/9 Nominating and Corporate Governance Committee 4/4 Finance and Transactions Committee 7/7 Special Transactions Committee 4/4
2022-05-02	Ms. Kavanagh has served on the Board since July 2016. ... 2021 Meeting Attendance: Board 8/8, Audit and Risk Committee 10/10, Nominating and Corporate Governance Committee 10/10, Finance and Transactions Committee 4/4, Special Transactions Committee 5/5.
2023-04-06	Ms. Kavanagh has served on the Board since July 2016. She is currently a corporate director. From 2011 through May 2016, Ms. Kavanagh served as a Commissioner of the Ontario Securities Commission, where she also served as chairperson of the audit committee starting in 2014. Between 1999 and 2010, Ms. Kavanagh served in various senior investment banking roles at Scotia Capital Inc., including Vice-Chair and Co-Head of Diversified Industries Group, Head of Equity Capital Markets, and Head of Investment Banking. Prior to Scotia Capital, she held several senior financial positions with operating companies. She started her career as an investment banker with a multinational bank in New York. Ms. Kavanagh graduated from Harvard Business School with a Master of Business Administration and received a Bachelor of Arts degree in Economics from Williams College. Ms. Kavanagh joined the board of directors of Bausch + Lomb Corporation, a publicly traded eye health company, in May 2022. Since 2013, Ms. Kavanagh has been a director of Hudbay Minerals Inc., a publicly traded Canadian mining corporation Ms. Kavanagh previously served as a member of the board of trustees of WPT Industrial REIT, a publicly traded open-ended real estate investment trust, from 2013 to October 2021. In addition to her public company directorships, she is a director of AST and Cymax Technology Group and also serves as a director of Sustainable Development Technology Canada. She completed the Directors Education Program at the Institute of Corporate Directors in 2011. Stock Ownership: • 0 Common Shares — $0 • 117,447 Restricted Share Units (“RSUs”) (comprised of 83,060 vested RSUs — $631,256 and 34,387 unvested RSUs — $261,341) • Total Equity Value at Risk: $631,256, representing 126% of the Company’s current aggregate amount of $500,000 required under the share ownership guidelines for non-employee Directors and 631% of the annual Board retainer. 2022 Meeting Attendance: • Board: 13 /13 • Audit & Risk Committee: 8/8 • Nominating & Corporate Governance Committee: 6/6 • Finance & Transactions Committee: 13/13 • Special Transactions Committee: 2/2 Qualifications: The Board has determined that Ms. Kavanagh’s extensive experience of complex financial and capital market issues at various banking institutions, and her in-depth knowledge of financial and operational matters qualify her to serve as a member of the Board and the committees on which she serves.
2024-04-04	Ms. Kavanagh has served on the Board since July 2016. She is currently a corporate director. From 2011 through May 2016, Ms. Kavanagh served as a Commissioner of the Ontario Securities Commission, where she also served as chairperson of the audit committee starting in 2014. Between 1999 and 2010, Ms. Kavanagh served in various senior investment banking roles at Scotia Capital Inc., including Vice-Chair and Co-Head of Diversified Industries Group, Head of Equity Capital Markets, and Head of Investment Banking. Prior to Scotia Capital, she held several senior financial positions with operating companies. She started her career as an investment banker with a bulge bracket firm in New York. Ms. Kavanagh graduated from Harvard Business School with a Master of Business Administration and received a Bachelor of Arts degree in Economics from Williams College. Ms. Kavanagh joined the board of directors of Bausch + Lomb Corporation, a publicly traded eye health company, in May 2022. Since 2013, Ms. Kavanagh has been a director of Hudbay Minerals Inc., a publicly traded Canadian mining corporation. Ms. Kavanagh previously served as a member of the board of trustees of WPT Industrial REIT, a publicly traded open-ended real estate investment trust, from March 2013 to October 2021. In addition to her public company directorships, she is a director of Cymax Technology Group and serves as a director of Sustainable Development Technology Canada. She completed the Directors Education Program at the Institute of Corporate Directors in 2011. Stock Ownership: 0 Common Shares — $0; 146,652 RSUs (comprised of 117,447 vested RSUs — $1,080,512 and 29,205 unvested RSUs — $268,686). Total Equity Value at Risk: $1,080,512, representing 216% of the Company’s current aggregate amount of $500,000 required under the share ownership guidelines for non-employee Directors and 1,081% of the annual Board retainer. 2023 Meeting Attendance: Board: 8 /8; Audit & Risk Committee: 8/8; Nominating & Corporate Governance Committee: 2/2; Finance & Transactions Committee: 7/7. The Board has determined that Ms. Kavanagh’s extensive experience with complex financial and capital market issues at various banking institutions, and her in-depth knowledge of financial and operational matters qualify her to serve as a member of the Board and the committees on which she serves.
2025-04-02	Ms. Kavanagh is currently a corporate director. ... Committees: Audit & Risk Committee, Finance & Transactions Committee. ... Director Compensation Table shows total compensation of $729,986.